Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

This report updates the 2009 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine for the prevention and control of influenza (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2009;58[No. RR-8] and CDC. Use of influenza A (H1N1) 2009 monovalent vaccine---recommendations of the Advisory Committee on Immunization Practices [ACIP], 2009. MMWR 2009;58:[No. RR-10]). The 2010 influenza recommendations include new and updated information. Highlights of the 2010 recommendations include 1) a recommendation that annual vaccination be administered to all persons aged >or=6 months for the 2010-11 influenza season; 2) a recommendation that children aged 6 months--8 years whose vaccination status is unknown or who have never received seasonal influenza vaccine before (or who received seasonal vaccine for the first time in 2009-10 but received only 1 dose in their first year of vaccination) as well as children who did not receive at least 1 dose of an influenza A (H1N1) 2009 monovalent vaccine regardless of previous influenza vaccine history should receive 2 doses of a 2010-11 seasonal influenza vaccine (minimum interval: 4 weeks) during the 2010--11 season; 3) a recommendation that vaccines containing the 2010-11 trivalent vaccine virus strains A/California/7/2009 (H1N1)-like (the same strain as was used for 2009 H1N1 monovalent vaccines), A/Perth/16/2009 (H3N2)-like, and B/Brisbane/60/2008-like antigens be used; 4) information about Fluzone High-Dose, a newly approved vaccine for persons aged >or=65 years; and 5) information about other standard-dose newly approved influenza vaccines and previously approved vaccines with expanded age indications. Vaccination efforts should begin as soon as the 2010-11 seasonal influenza vaccine is available and continue through the influenza season. These recommendations also include a summary of safety data for U.S.-licensed influenza vaccines. These recommendations and other information are available at CDC's influenza website (http://www.cdc.gov/flu); any updates or supplements that might be required during the 2010-11 influenza season also will be available at this website. Recommendations for influenza diagnosis and antiviral use will be published before the start of the 2010-11 influenza season. Vaccination and health-care providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information.

[1]  John W. Harris,et al.  INFLUENZA OCCURRING IN PREGNANT WOMEN: A STATISTICAL STUDY OF THIRTEEN HUNDRED AND FIFTY CASES , 1919 .

[2]  D. Freeman,et al.  Deaths from Asian influenza associated with pregnancy. , 1959, American journal of obstetrics and gynecology.

[3]  D. E. Rogers,et al.  Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. , 1959, The Journal of clinical investigation.

[4]  D. Widelock,et al.  Influenza, pregnancy, and fetal outcome. , 1963, Public health reports.

[5]  A. Monto,et al.  Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. , 1970, The Journal of infectious diseases.

[6]  S. Shapiro,et al.  Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. , 1973, International Journal of Epidemiology.

[7]  M. Cooney,et al.  A Hong Kong influenza immunity three years after immunization. , 1973, JAMA.

[8]  J. Fox,et al.  The Seattle Virus Watch. VI. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae. , 1975, American journal of epidemiology.

[9]  A. Monto,et al.  The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. , 1975, American journal of epidemiology.

[10]  A. Hampson,et al.  Antibody response to one and two doses of influenza virus subunit vaccine. , 1976, The Medical journal of Australia.

[11]  H. D. Hochstein,et al.  Comparative trial of influenza vaccines. II. Adverse reactions in children and adults. , 1976, American journal of epidemiology.

[12]  W. Vaughn,et al.  Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. , 1977, The Journal of infectious diseases.

[13]  W. Dowdle,et al.  Swine influenza virus infections in humans. , 1977, The Journal of infectious diseases.

[14]  R. Couch,et al.  Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.

[15]  T. D. Bell,et al.  Immunization with killed influenza virus in children with chronic asthma. , 1978, Chest.

[16]  S. Schoenbaum,et al.  Respiratory infection in pregnancy. , 1979, Clinical obstetrics and gynecology.

[17]  J A Bryan,et al.  Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.

[18]  R. Gibbs,et al.  Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. , 1979, The Journal of infectious diseases.

[19]  C W Potter,et al.  Determinants of immunity to influenza infection in man. , 1979, British medical bulletin.

[20]  J. Oxford,et al.  The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection , 1979, Journal of Hygiene.

[21]  J. Mullooly,et al.  Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.

[22]  P. Griffiths,et al.  A prospective study of influenza infections during pregnancy. , 1980, Journal of Epidemiology and Community Health.

[23]  J. Puck,et al.  Protection of infants from infection with influenza A virus by transplacentally acquired antibody. , 1980, The Journal of infectious diseases.

[24]  A. Deinard,et al.  A/NJ/8/76 influenza vaccination program: effects on maternal health and pregnancy outcome. , 1981, American journal of obstetrics and gynecology.

[25]  R. Holman,et al.  Guillain-Barré syndrome and the 1978-1979 influenza vaccine. , 1981, The New England journal of medicine.

[26]  L. Schonberger,et al.  Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. , 1982, JAMA.

[27]  J. Mullooly,et al.  Impact of type A influenza on children: a retrospective study. , 1982, American journal of public health.

[28]  J. L. Montagne,et al.  Summary of clinical trials of inactivated influenza vaccine - 1978. , 1983, Reviews of infectious diseases.

[29]  A. Monto,et al.  Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. , 1983, Reviews of infectious diseases.

[30]  R B Couch,et al.  Immunity to influenza in man. , 1983, Annual review of microbiology.

[31]  C. Hall,et al.  Influenza A virus infection imitating bacterial sepsis in early infancy , 1984, Pediatric infectious disease.

[32]  R. Couch,et al.  Sporadic occurrence of zoonotic swine influenza virus infections , 1984, Journal of clinical microbiology.

[33]  R. Strunk,et al.  Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins. , 1985, The Journal of pediatrics.

[34]  A. Kendal,et al.  Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic. , 1985, JAMA.

[35]  B. Murphy,et al.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.

[36]  W. Barker,et al.  Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. , 1986, American journal of public health.

[37]  A. Kendal,et al.  Risk factors for outbreaks of influenza in nursing homes. A case-control study. , 1986, American journal of epidemiology.

[38]  J. Mullooly,et al.  Risk of acute respiratory disease among pregnant women during influenza A epidemics. , 1986, Public health reports.

[39]  V. Baker,et al.  Fatal Influenza a Pneumonia in Pregnancy , 1986, American journal of perinatology.

[40]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[41]  Update: influenza activity--United States. , 1986, MMWR. Morbidity and mortality weekly report.

[42]  W. P. Glezen,et al.  Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.

[43]  R. Douglas,et al.  Immunization of elderly people with two doses of influenza vaccine , 1987, Journal of clinical microbiology.

[44]  B. L. Beattie,et al.  Comparison of one- and two-dose regimens of influenza vaccine for elderly men. , 1987, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[45]  L. Kingsley,et al.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. , 1987, JAMA.

[46]  D. Tyrrell Options for the Control of Influenza , 1987 .

[47]  E. Ayoub,et al.  Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs. , 1987, The Pediatric infectious disease journal.

[48]  J. Rowe Report of the Institute of Medicine , 1987 .

[49]  R. Carpenter,et al.  Favorable outcome after treatment with amantadine and ribavirin in a pregnancy complicated by influenza pneumonia. A case report. , 1988, The Journal of reproductive medicine.

[50]  J. Margolick,et al.  The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. , 1989, JAMA.

[51]  K. Nichol,et al.  Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. , 1990, JAMA.

[52]  W. Raub From the National Institutes of Health. , 1990, JAMA.

[53]  B. L. Beattie,et al.  Age‐Related Decline in Interleukin 2 Production in Response to Influenza Vaccine , 1990, Journal of the American Geriatrics Society.

[54]  L. Kirkland Ocular Sensitivity to Thimerosal: A Problem With Hepatitis B Vaccine? , 1990, Southern medical journal.

[55]  J. Mills,et al.  Influenza in patients with human immunodeficiency virus infection. , 1990, Chest.

[56]  W. P. Glezen,et al.  Morbidity associated with the major respiratory viruses. , 1990, Pediatric annals.

[57]  R. Couch,et al.  Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. , 1991, The Journal of infectious diseases.

[58]  M. Levin,et al.  Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. , 1991, Pediatrics.

[59]  T. Heikkinen,et al.  Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.

[60]  W. Aberer Vaccination despite thimerosal sensitivity , 1991, Contact dermatitis.

[61]  D. Ho HIV-1 viraemia and influenza , 1992, The Lancet.

[62]  D. Morse,et al.  An Outbreak of Influenza A (H3N2) in a Well Immunized Nursing Home Population , 1992, Journal of the American Geriatrics Society.

[63]  G. Dinant,et al.  Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial. , 1993, BMJ.

[64]  W. P. Glezen,et al.  Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. , 1993, The Journal of infectious diseases.

[65]  Larry K. Pickering,et al.  General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[66]  K. Edwards,et al.  Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. , 1994, The Pediatric infectious disease journal.

[67]  N. Sugaya,et al.  Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. , 1994, JAMA.

[68]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[69]  M. Levin,et al.  Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. , 1994, Vaccine.

[70]  M. Hornbrook,et al.  Influenza Vaccination Programs for Elderly Persons: Cost-Effectiveness in a Health Maintenance Organization , 1994, Annals of Internal Medicine.

[71]  R. Jonsson,et al.  Parenteral influenza vaccination induces a rapid systemic and local immune response. , 1995, The Journal of infectious diseases.

[72]  H. Sacks,et al.  The Efficacy of Influenza Vaccine in Elderly Persons , 1995, Annals of Internal Medicine.

[73]  K. Nichol,et al.  The effectiveness of vaccination against influenza in healthy, working adults. , 1995, The New England journal of medicine.

[74]  W. O'brien,et al.  Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.

[75]  T. Elbeik,et al.  Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.

[76]  E. Walter,et al.  Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. , 1995, Archives of Pediatrics & Adolescent Medicine.

[77]  J. Flynn,et al.  Effective immunization against influenza in pediatric renal transplant recipients. , 1996, Clinical transplantation.

[78]  Marie Gauthier,et al.  1994 Red Book: Report of the Committee on Infectious Diseases , 1996 .

[79]  A. Frank,et al.  Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. , 1996, Pediatrics.

[80]  J. Margolick,et al.  The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. , 1996, The Journal of infectious diseases.

[81]  K. Nichol,et al.  Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. , 1996, Archives of internal medicine.

[82]  J. Banks,et al.  Avian influenza virus isolated from a woman with conjunctivitis , 1996, The Lancet.

[83]  B. Breuer,et al.  Sequential Outbreak of Influenza A and B in a Nursing Home: Efficacy of Vaccine and Amantadine , 1996, Journal of the American Geriatrics Society.

[84]  B. O'Donnell,et al.  Incidence and recall of influenza in a cohort of Glasgow healthcare workers during the 1993–4 epidemic: results of serum testing and questionnaire , 1996, BMJ.

[85]  F. Hayden,et al.  The immunogenicity of influenza virus vaccine in solid organ transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[86]  Y. Hirota,et al.  Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. , 1997, Vaccine.

[87]  P. Gross,et al.  Time to earliest peak serum antibody response to influenza vaccine in the elderly , 1997, Clinical and diagnostic laboratory immunology.

[88]  D. Stott,et al.  Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients , 1997, The Journal of infectious diseases.

[89]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[90]  E. Ong,et al.  Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults and healthy volunteers , 1997, International journal of STD & AIDS.

[91]  L. Simonsen,et al.  The impact of influenza epidemics on mortality: introducing a severity index. , 1997, American journal of public health.

[92]  D. Campbell,et al.  Cost-effectiveness of the influenza vaccine in a healthy, working-age population. , 1997, Journal of occupational and environmental medicine.

[93]  H. Kessler,et al.  Immunologic and virologic evaluation after influenza vaccination of HIV‐1‐infected patients , 1997, AIDS.

[94]  R. Kerstens,et al.  IMMUNOGENICITY AND TOLERABILITY OF A TRIVALENT INFLUENZA SUBUNIT VACCINE (INFLUVAC®) IN HIGH‐RISK CHILDREN AGED 6 MONTHS TO 4 YEARS , 1997, The British journal of clinical practice.

[95]  D. Bernstein,et al.  Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. , 1998, The Journal of infectious diseases.

[96]  M. Guarino,et al.  Campylobacter jejuni infection and Guillain-Barré syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology. , 1998, Neuroepidemiology.

[97]  J. Mandel,et al.  Absenteeism among employees who participated in a workplace influenza immunization program. , 1998, Journal of occupational and environmental medicine.

[98]  H. Sampson,et al.  Safe administration of influenza vaccine to patients with egg allergy. , 1998, The Journal of pediatrics.

[99]  G. Mckhann,et al.  Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome , 1998, Neurology.

[100]  F. Hayden,et al.  The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. , 1998, The New England journal of medicine.

[101]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[102]  L. Magder,et al.  The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. , 1998, The New England journal of medicine.

[103]  L. Simonsen,et al.  Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. , 1998, American journal of epidemiology.

[104]  P. Schmitz,et al.  The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.

[105]  A. Kaplan,et al.  Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. , 1998, Vaccine.

[106]  Recommendations regarding the use of vaccines that contain thimerosal as a preservative. , 1999, MMWR. Morbidity and mortality weekly report.

[107]  B. Ashby-Hughes,et al.  Provider endorsement: the strongest cue in prompting high-risk adults to receive influenza and pneumococcal immunizations. , 1999, Clinical excellence for nurse practitioners : the international journal of NPACE.

[108]  E. Toy,et al.  Influenza Vaccination in Pregnancy , 1999, American journal of perinatology.

[109]  R. Betts,et al.  Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. , 1999, Vaccine.

[110]  A. Haverich,et al.  Influenza vaccination in heart transplant recipients. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[111]  L. Jackson,et al.  Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions. , 1999, Vaccine.

[112]  N. Cox,et al.  Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[113]  R. Couch Influenza, influenza virus vaccine, and human immunodeficiency virus infection. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  K. Neuzil,et al.  Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.

[115]  A. Monto,et al.  Effectiveness of Inactivated Influenza Vaccine Among Nursing Home Residents During an Influenza Type A (H3N2) Epidemic , 1999, Journal of the American Geriatrics Society.

[116]  W. Gruber,et al.  Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children. , 1999 .

[117]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[118]  M. Steinhoff,et al.  Effectiveness of influenza vaccine in health care professionals: a randomized trial. , 1999, JAMA.

[119]  M. Nettleman,et al.  Potential Cost Savings Attributable to Influenza Vaccination of School-aged Children , 1999, Pediatrics.

[120]  Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. , 1999, JAMA.

[121]  S. Salmaso,et al.  Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination. , 1999, Vaccine.

[122]  Karen McAulay,et al.  Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial , 2000, The Lancet.

[123]  B. Gonik,et al.  The Obstetrician‐Gynecologist's Role in Vaccine‐Preventable Diseases and Immunization , 2000, Obstetrics and gynecology.

[124]  K. Neuzil,et al.  The burden of influenza illness in children with asthma and other chronic medical conditions. , 2000, The Journal of pediatrics.

[125]  Lihan K. Yan,et al.  Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. , 2000, The Journal of infectious diseases.

[126]  R. Davis,et al.  Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.

[127]  M. Cetron,et al.  Cruise ships: high-risk passengers and the global spread of new influenza viruses. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[128]  R. Cunney,et al.  An Outbreak of Influenza A in a Neonatal Intensive Care Unit , 2000, Infection Control & Hospital Epidemiology.

[129]  D. Bratzler,et al.  Hospital-Based Influenza and Pneumococcal Vaccination: Sutton's Law Applied to Prevention , 2000, Infection Control & Hospital Epidemiology.

[130]  K. K. Lai,et al.  Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[131]  Lihan K. Yan,et al.  Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. , 2000, The Journal of infectious diseases.

[132]  M. Nettleman,et al.  Economic Impact of Influenza Vaccination in Preschool Children , 2000, Pediatrics.

[133]  T. Jefferson,et al.  Vaccines for preventing influenza in people with asthma. , 2000, The Cochrane database of systematic reviews.

[134]  P. Fast,et al.  Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial , 2000, Journal of Clinical Microbiology.

[135]  E F Mitchel,et al.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.

[136]  J. McElhaney,et al.  Standing orders for influenza vaccination increased vaccination rates in inpatient settings compared with community rates. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[137]  R. Davis,et al.  The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA. , 2000, Bulletin of the World Health Organization.

[138]  L. Simonsen,et al.  The impact of influenza epidemics on hospitalizations. , 2000, The Journal of infectious diseases.

[139]  N. Cox,et al.  Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. , 2000, JAMA.

[140]  Lihan K. Yan,et al.  Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. , 2000, The Journal of pediatrics.

[141]  P. Sullivan,et al.  Effect of influenza vaccination on disease progression among HIV-infected persons , 2000, AIDS.

[142]  H. Dibarboure,et al.  Safety and immunogenicity of a paediatric presentation of an influenza vaccine , 2000, Archives of disease in childhood.

[143]  R. Couch,et al.  Impact of respiratory virus infections on persons with chronic underlying conditions. , 2000, JAMA.

[144]  R. Haubrich,et al.  Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. , 2000, The Journal of infectious diseases.

[145]  R. Wood‐Baker,et al.  Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.

[146]  J. Oxford,et al.  Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study , 2000, BJOG : an international journal of obstetrics and gynaecology.

[147]  J. D. de Jong,et al.  Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. , 2000, Vaccine.

[148]  W. Gruber,et al.  Prevention of otitis media in children with live attenuated influenza vaccine given intranasally. , 2000, The Pediatric infectious disease journal.

[149]  L. Rodewald,et al.  Use of standing orders programs to increase adult vaccination rates. , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[150]  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season. , 2001, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[151]  K. Nichol,et al.  Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. , 2001, Archives of internal medicine.

[152]  Robert T. Chen,et al.  Does influenza vaccination prevent asthma exacerbations in children? , 2001, The Journal of pediatrics.

[153]  G. Dayan,et al.  Cost-effectiveness of influenza vaccination in high-risk children in Argentina. , 2001, Vaccine.

[154]  D. Ehlert,et al.  Influenza vaccination is safe and immunogenic when administered to hospitalized patients. , 2001, Vaccine.

[155]  Lihan K. Yan,et al.  Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. , 2001, The Pediatric Infectious Disease Journal.

[156]  K. Nichol,et al.  Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. , 2001, The Journal of infectious diseases.

[157]  M. McCormick,et al.  Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders , 2001 .

[158]  W. Dupont,et al.  Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience , 2001, The Pediatric infectious disease journal.

[159]  A. Monto,et al.  Influenza vaccine effectiveness among elderly nursing home residents: a cohort study. , 2001, American journal of epidemiology.

[160]  K. Nichol,et al.  Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. , 2001, Archives of internal medicine.

[161]  R. M. Hendry,et al.  Immune response to influenza vaccine in adult liver transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[162]  S. M. Marcy,et al.  Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. , 2001, The Pediatric infectious disease journal.

[163]  Lihan K. Yan,et al.  Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. , 2001, Pediatrics.

[164]  M. Gaglani,et al.  A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease , 2001, The Pediatric infectious disease journal.

[165]  C. Bridges,et al.  Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[166]  E. Tanzi,et al.  Influenza vaccination of HIV‐1‐positive and hiv‐1‐negative former intravenous drug users , 2001, Journal of medical virology.

[167]  T. Ezzati-Rice,et al.  Comparison of NIS and NHIS/NIPRCS vaccination coverage estimates. National Immunization Survey. National Health Interview Survey/National Immunization Provider Record Check Study. , 2001, American journal of preventive medicine.

[168]  Yuan-ji Guo,et al.  Influenza activity in China: 1998-1999. , 2002, Vaccine.

[169]  G. Redding,et al.  Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma , 2002, The Pediatric infectious disease journal.

[170]  K. Edwards,et al.  Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. , 2002, The Journal of infectious diseases.

[171]  D. Skowronski,et al.  Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season. , 2002, Vaccine.

[172]  C. Olsen The emergence of novel swine influenza viruses in North America. , 2002, Virus research.

[173]  马建新,et al.  呼吸机相关性肺炎的非侵入性与侵入性检查 [英]/Ruiz M…//Am J Respir Crit Care Med , 2002 .

[174]  R. Zeiger Current issues with influenza vaccination in egg allergy. , 2002, The Journal of allergy and clinical immunology.

[175]  L. Brammer,et al.  Serologic Evidence of H1 Swine Influenza Virus Infection in Swine Farm Residents and Employees , 2002, Emerging infectious diseases.

[176]  D. Skowronski,et al.  Low risk of recurrence of oculorespiratory syndrome following influenza revaccination. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[177]  J. Lopreiato,et al.  For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .

[178]  J. Fish,et al.  The safety of inactivated influenza vaccine in adults and children with asthma , 2001 .

[179]  R. Hughes,et al.  Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation , 2002, Journal of neurology, neurosurgery, and psychiatry.

[180]  K. Nichol,et al.  Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[181]  Hhs Centers for Medicare Medicare Services Medicare and Medicaid programs; conditions of participation: immunization standards for hospitals, long-term care facilities, and home health agencies. Final rule with comment period. , 2002, Federal register.

[182]  D. Bratzler,et al.  Failure to vaccinate Medicare inpatients: a missed opportunity. , 2002, Archives of internal medicine.

[183]  A. Detsky,et al.  Use of, Effectiveness of, and Attitudes Regarding Influenza Vaccine Among House Staff , 2003, Infection Control & Hospital Epidemiology.

[184]  R. Walker,et al.  Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. , 2003, Vaccine.

[185]  Susanna Esposito,et al.  Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. , 2003, Vaccine.

[186]  Robert L Davis,et al.  Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. , 2003, Pediatrics.

[187]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[188]  M. Fine,et al.  Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. , 2003, Vaccine.

[189]  L. Sehulster,et al.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[190]  D. Skowronski,et al.  Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[191]  Lihan K. Yan,et al.  Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children , 2003, The Pediatric infectious disease journal.

[192]  J. Treanor,et al.  Immune correlates of protection against influenza in the human challenge model. , 2003, Developments in biologicals.

[193]  R. Dittus,et al.  Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. , 2003, American journal of obstetrics and gynecology.

[194]  M. Cetron,et al.  Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[195]  R. Davis,et al.  Risk of anaphylaxis after vaccination of children and adolescents. , 2003, Pediatrics.

[196]  K. Nichol,et al.  Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. , 2003, Vaccine.

[197]  Robert T. Chen,et al.  Guillain-Barré syndrome following influenza vaccination , 2004, Reactions Weekly.

[198]  Robert L Davis,et al.  Safety of the trivalent inactivated influenza vaccine among children: a population-based study. , 2004, Archives of pediatrics & adolescent medicine.

[199]  R. Walker,et al.  Measuring Antibody Responses to a Live Attenuated Influenza Vaccine in Children , 2004, The Pediatric infectious disease journal.

[200]  Theresa E. Fuller,et al.  Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons. , 2004, Archives of internal medicine.

[201]  E. Lewis,et al.  Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents , 2004, The Pediatric infectious disease journal.

[202]  E. Gurfinkel,et al.  Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. , 2004, European heart journal.

[203]  Benjamin Schwartz,et al.  Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. , 2004, Pediatrics.

[204]  M. Halloran,et al.  Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. , 2004, Archives of pediatrics & adolescent medicine.

[205]  J. Gerberding,et al.  Update: influenza activity--United States and worldwide, 2003-04 season, and composition of the 2004-05 influenza vaccine. , 2004, MMWR. Morbidity and mortality weekly report.

[206]  R. Belshe,et al.  Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination , 2004, The Pediatric infectious disease journal.

[207]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[208]  S. Black,et al.  Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. , 2004, American journal of perinatology.

[209]  F. Hayden,et al.  Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians , 2004, Infection Control & Hospital Epidemiology.

[210]  W. Dejsomritrutai,et al.  Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. , 2004, Chest.

[211]  A. Branch,et al.  Influenza Vaccination in Orthotopic Liver Transplant Recipients: Absence of Post Administration ALT Elevation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[212]  D. Krysan Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. , 2004, The Journal of pediatrics.

[213]  N. Cox,et al.  Reassortment and evolution of current human influenza A and B viruses. , 2004, Virus research.

[214]  R. Walker,et al.  Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[215]  M. Moss RISK OF ANAPHYLAXIS AFTER VACCINATION OF CHILDREN AND ADOLESCENTS , 2004, Pediatrics.

[216]  A. Osterhaus,et al.  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .

[217]  Marion Koopmans,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[218]  J. Stoddard,et al.  Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine , 2004, Expert review of vaccines.

[219]  E. Rosenberg,et al.  Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[220]  T. Lieu,et al.  Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. , 2004, Pediatrics.

[221]  Ray Higginson,et al.  The threat of an avian influenza pandemic. , 2005, British journal of nursing.

[222]  Interventions to increase influenza vaccination of health-care workers--California and Minnesota. , 2005, MMWR. Morbidity and mortality weekly report.

[223]  Pedro A Piedra,et al.  Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial , 2005, Pediatrics.

[224]  D. Grobbee,et al.  Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. , 2005, Archives of internal medicine.

[225]  J. Raphaël,et al.  [Guillain-Barré syndrome]. , 2005, La Revue du praticien.

[226]  Bruce A. Ong,et al.  DOES INFLUENZA VACCINATION IMPROVE PEDIATRIC ASTHMA OUTCOMES , 2005 .

[227]  K. Edwards,et al.  Increasing Rates of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus in Healthy Children , 2005, The Pediatric infectious disease journal.

[228]  M. Nowalk,et al.  Parental perspectives on influenza immunization of children aged 6 to 23 months. , 2005, American journal of preventive medicine.

[229]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[230]  Susan S Ellenberg,et al.  Evaluating the safety of new vaccines: summary of a workshop. , 2005, American journal of public health.

[231]  J. McElhaney,et al.  The unmet need in the elderly: designing new influenza vaccines for older adults. , 2005, Vaccine.

[232]  D. Hopkins,et al.  Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[233]  S. Cosgrove,et al.  Influenza Vaccination of Healthcare Workers and Vaccine Allocation for Healthcare Workers During Vaccine Shortages , 2005, Infection Control &#x0026; Hospital Epidemiology.

[234]  Robert Ball,et al.  Adverse events reported following live, cold-adapted, intranasal influenza vaccine. , 2005, JAMA.

[235]  P. Briss,et al.  Interventions to improve influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among high-risk adults: a systematic review. , 2005, American journal of preventive medicine.

[236]  R. Stefanacci Creating artificial barriers to vaccinations. , 2005, Journal of the American Medical Directors Association.

[237]  Keiji Fukuda,et al.  Influenza-associated deaths among children in the United States, 2003-2004. , 2005, The New England journal of medicine.

[238]  K. W. Harris,et al.  The Guide to Community Preventive Services , 2005 .

[239]  A. Kaira,et al.  The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly , 2005, Epidemiology and Infection.

[240]  S. Rosenbaum,et al.  The epidemiology of u.s. immunization law: immunization requirements for staff and residents of long-term care facilities under state laws/regulations. , 2005 .

[241]  V Demicheli,et al.  Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review , 2005, The Lancet.

[242]  R. Keren,et al.  Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. , 2005, JAMA.

[243]  A. Monto,et al.  A Comparison of 2 Influenza Vaccine Schedules in 6- to 23-Month-Old Children , 2005, Pediatrics.

[244]  M. Kolczak,et al.  Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.

[245]  Hhs Centers for Medicare Medicare Services Medicare and Medicaid programs; condition of participation: immunization standard for long term care facilities. Final rule. , 2005, Federal register.

[246]  R. Jacobson,et al.  Requiring influenza vaccination for health care workers: seven truths we must accept. , 2005, Vaccine.

[247]  John Painter,et al.  Effect of handwashing on child health: a randomised controlled trial , 2005, The Lancet.

[248]  M. Meltzer,et al.  An economic analysis of annual influenza vaccination of children. , 2005, Vaccine.

[249]  M. Meltzer,et al.  Estimating medical practice expenses from administering adult influenza vaccinations. , 2005, Vaccine.

[250]  Pedro A Piedra,et al.  Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. , 2005, Vaccine.

[251]  R. Kane,et al.  The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries. , 2005, Health services research.

[252]  R. Saito,et al.  Antibody Response to Influenza Vaccination in Nursing Home Residents and Healthcare Workers During Four Successive Seasons in Niigata, Japan , 2005, Infection Control &#x0026; Hospital Epidemiology.

[253]  K. Edwards,et al.  Infection Control and Hospital Epidemiology Duration of Virus Shedding after Trivalent Intranasal Live Attenuated Influenza Vaccination in Adults , 2022 .

[254]  Peter Szilagyi,et al.  Patient reminder and patient recall systems to improve immunization rates. , 2005, The Cochrane database of systematic reviews.

[255]  Giovanni Apolone,et al.  Influenza vaccine in healthy children: a meta-analysis. , 2005, Vaccine.

[256]  A. Hay,et al.  Influenza virus infection in travelers to tropical and subtropical countries. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[257]  A. Monto,et al.  Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. , 2006, The New England journal of medicine.

[258]  P. Wortley,et al.  Factors Associated with Vaccination of Medicare Beneficiaries in Five U.S. Communities: Results from the Racial and Ethnic Adult Disparities in Immunization Initiative Survey, 2003 , 2006, Journal of the American Geriatrics Society.

[259]  L. Solberg,et al.  Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. , 2006, American journal of preventive medicine.

[260]  C. Glaser,et al.  Severe Pediatric Influenza in California, 2003–2005: Implications for Immunization Recommendations , 2006, Pediatrics.

[261]  K. Nichol Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. , 2006, Vaccine.

[262]  B. Psaty,et al.  Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. , 2006, International journal of epidemiology.

[263]  M. Sidhu,et al.  Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. , 2006, Virology.

[264]  A. Naleway,et al.  Delivering influenza vaccine to pregnant women. , 2006, Epidemiologic reviews.

[265]  R. Keren,et al.  Direct Medical Cost of Influenza-Related Hospitalizations in Children , 2006, Pediatrics.

[266]  Thomas V Inglesby,et al.  Disease mitigation measures in the control of pandemic influenza. , 2006, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[267]  A. Monto,et al.  Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers , 2006, Pediatrics.

[268]  T. Jefferson,et al.  Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. , 2006, The Lancet. Infectious diseases.

[269]  R. Couch,et al.  Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. , 2006, Archives of internal medicine.

[270]  Robert L Davis,et al.  Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. , 2006, JAMA.

[271]  New infection control requirement for offering influenza vaccination to staff and licensed independent practitioners. , 2006, Joint Commission perspectives. Joint Commission on Accreditation of Healthcare Organizations.

[272]  S. Cox,et al.  Hospitalizations With Respiratory Illness Among Pregnant Women During Influenza Season , 2006, Obstetrics and gynecology.

[273]  U. Wahn,et al.  Comparison of the Efficacy and Safety of Live Attenuated Cold-Adapted Influenza Vaccine, Trivalent, With Trivalent Inactivated Influenza Virus Vaccine in Children and Adolescents With Asthma , 2006, The Pediatric infectious disease journal.

[274]  J. McCullers,et al.  Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. , 2006, The Journal of infectious diseases.

[275]  E. Thacker,et al.  Are swine workers in the United States at increased risk of infection with zoonotic influenza virus? , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[276]  Harlan M Krumholz,et al.  Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. , 2006, Journal of the American College of Cardiology.

[277]  W. Gruber,et al.  Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.

[278]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[279]  K. Nichol,et al.  Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. , 2006, Vaccine.

[280]  W. Hanshaoworakul,et al.  Investigation of avian influenza (H5N1) outbreak in humans--Thailand, 2004. , 2006, MMWR supplements.

[281]  W. Schaffner,et al.  Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 , 2006, The Pediatric infectious disease journal.

[282]  A. Oner,et al.  Avian influenza A (H5N1) infection in eastern Turkey in 2006. , 2006, The New England journal of medicine.

[283]  C. Byington,et al.  Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection , 2006, Pediatrics.

[284]  A. Monto,et al.  Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming? , 2005, Pediatrics.

[285]  K. Nichol,et al.  Do recommended high-risk adults benefit from a first influenza vaccination? , 2006, Vaccine.

[286]  A. Gilsdorf,et al.  Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[287]  D. Fleming,et al.  Safety, Efficacy, and Effectiveness of Cold-Adapted Influenza Vaccine-Trivalent Against Community-Acquired, Culture-Confirmed Influenza in Young Children Attending Day Care , 2006, Pediatrics.

[288]  Lawrence O Gostin,et al.  Medical countermeasures for pandemic influenza: ethics and the law. , 2006, JAMA.

[289]  J. Nguyen-Van-Tam,et al.  Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[290]  C. Bridges,et al.  Influenza Vaccination of Health-Care Personnel Recommendations of the Healthcare Infection Control Practices Advisory Committee ( HICPAC ) and the Advisory Committee on Immunization Practices ( ACIP ) , 2006 .

[291]  T. Lieu,et al.  Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children , 2006, Emerging infectious diseases.

[292]  N. Brewer,et al.  Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[293]  C. Bridges,et al.  The underrecognized burden of influenza in young children. , 2006, The New England journal of medicine.

[294]  A. Razmpour,et al.  A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine , 2006, The Pediatric infectious disease journal.

[295]  N. Cox,et al.  Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model , 2006, Proceedings of the National Academy of Sciences.

[296]  T. Lieu,et al.  Parental Perspectives on Influenza Vaccination among Children with Asthma , 2006, Public health reports.

[297]  Mandy A. Allison,et al.  Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. , 2006, The Journal of pediatrics.

[298]  S. Black,et al.  Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants. , 2006, Archives of pediatrics & adolescent medicine.

[299]  Ross E. G. Upshur,et al.  Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. , 2006, Archives of internal medicine.

[300]  Mark A. Miller,et al.  US flu mortality estimates are based on solid science , 2006, BMJ : British Medical Journal.

[301]  K. Nichol,et al.  Vaccines for seasonal and pandemic influenza. , 2006, The Journal of infectious diseases.

[302]  C. Bridges,et al.  Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. , 2006, The Journal of infectious diseases.

[303]  Florence T. Bourgeois,et al.  Influenza and Other Respiratory Virus–Related Emergency Department Visits Among Young Children , 2006, Pediatrics.

[304]  N. Tien,et al.  Risk Factors for Human Infection with Avian Influenza A H5N1, Vietnam, 2004 , 2006, Emerging infectious diseases.

[305]  J. Nelson,et al.  Evidence of bias in estimates of influenza vaccine effectiveness in seniors. , 2006, International journal of epidemiology.

[306]  P. Horby,et al.  Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures , 2006, Emerging infectious diseases.

[307]  Yi Guan,et al.  Three Indonesian clusters of H5N1 virus infection in 2005. , 2006, The New England journal of medicine.

[308]  Anne M Johnson,et al.  Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial , 2006, BMJ : British Medical Journal.

[309]  Gregory C Gray,et al.  Cases of swine influenza in humans: a review of the literature. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[310]  K. Fiscella,et al.  Impact of influenza vaccination disparities on elderly mortality in the United States. , 2007, Preventive medicine.

[311]  Collective Editorial team Avian influenza A/(H7N2) outbreak in the United Kingdom. , 2007, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[312]  R. Davis,et al.  Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. , 2007, The New England journal of medicine.

[313]  K. Nichol,et al.  Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.

[314]  T. Jefferson,et al.  Influenza vaccination for elderly people and their care workers , 2007, The Lancet.

[315]  R. Webby,et al.  Identification of H2N3 influenza A viruses from swine in the United States , 2007, Proceedings of the National Academy of Sciences.

[316]  I. Petersen,et al.  Guillain-Barré Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database , 2007, PloS one.

[317]  Ivan S F Chan,et al.  Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older , 2007, Journal of the American Geriatrics Society.

[318]  M. Irigoyen,et al.  Influenza Vaccine Coverage and Missed Opportunities Among Inner-city Children Aged 6 to 23 Months: 2000-2005 , 2007, Pediatrics.

[319]  W. P. Glezen,et al.  Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003–2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children , 2007, Pediatrics.

[320]  W. Schaffner,et al.  Mass Distribution of Free, Intranasally Administered Influenza Vaccine in a Public School System , 2007, Pediatrics.

[321]  L. Dodds,et al.  Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women , 2007, Canadian Medical Association Journal.

[322]  T. Jefferson,et al.  Cochrane Review: Interventions for the interruption or reduction of the spread of respiratory viruses , 2008, Evidence-based child health : a Cochrane review journal.

[323]  Influenza vaccination coverage among children with asthma--United States, 2004-05 influenza season. , 2007, MMWR. Morbidity and mortality weekly report.

[324]  C. Bridges,et al.  Influenza- and RSV-associated hospitalizations among adults. , 2007, Vaccine.

[325]  Farzad Mostashari,et al.  Monitoring the Impact of Influenza by Age: Emergency Department Fever and Respiratory Complaint Surveillance in New York City , 2007, PLoS medicine.

[326]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[327]  A. Razmpour,et al.  Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia , 2007, The Pediatric infectious disease journal.

[328]  R. Baltimore,et al.  Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006–2007 , 2007, Pediatrics.

[329]  C. Bridges,et al.  The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.

[330]  J. Raboud,et al.  Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[331]  C. Bridges,et al.  Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004 , 2007, Pediatrics.

[332]  F. Shaw,et al.  Assessing state immunization requirements for healthcare workers and patients. , 2007, American journal of preventive medicine.

[333]  S. Dreskin,et al.  Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[334]  D. Snydman Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006 , 2007 .

[335]  R. Keren,et al.  Incidence, Complications, and Risk Factors for Prolonged Stay in Children Hospitalized With Community-Acquired Influenza , 2007, Pediatrics.

[336]  C. Bridges,et al.  Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. , 2007, Vaccine.

[337]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[338]  Mph Dr. Kristin L. Nichol MD,et al.  Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults , 2007, Journal of General Internal Medicine.

[339]  Jan Bonhoeffer,et al.  Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. , 2007, Vaccine.

[340]  Robert J. Taylor,et al.  Effectiveness of influenza vaccination. , 2007, The New England journal of medicine.

[341]  A. Capuano,et al.  Swine Workers and Swine Influenza Virus Infections , 2007, Emerging infectious diseases.

[342]  R. Couch,et al.  Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. , 2007, Vaccine.

[343]  D. Christakis,et al.  Hospital-Based Influenza Vaccination of Children: An Opportunity to Prevent Subsequent Hospitalization , 2008, Pediatrics.

[344]  Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. , 2008, Releve epidemiologique hebdomadaire.

[345]  Lihan K. Yan,et al.  Mercury Levels in Newborns and Infants After Receipt of Thimerosal-Containing Vaccines , 2008, Pediatrics.

[346]  D. Skowronski,et al.  Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? , 2008, The Journal of infectious diseases.

[347]  James A Singleton,et al.  Influenza vaccination of recommended adult populations, U.S., 1989-2005. , 2008, Vaccine.

[348]  J. Gerberding,et al.  Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. , 2008, MMWR. Morbidity and mortality weekly report.

[349]  C. Bridges,et al.  Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Children 6 to 59 Months of Age During the 2003–2004 and 2004–2005 Influenza Seasons , 2008, Pediatrics.

[350]  A. Kumar,et al.  Three Indonesian Clusters of H5N1 Virus Infection in 2005 , 2008 .

[351]  W. P. Glezen,et al.  Safety of the Intranasal, Trivalent, Live Attenuated Influenza Vaccine (LAIV) in Children With Intermittent Wheezing in an Open-Label Field Trial , 2008, The Pediatric infectious disease journal.

[352]  J. Farrar,et al.  Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series , 2008, The Lancet.

[353]  B. Stricker,et al.  Mortality benefits of influenza vaccination in elderly people. , 2008, The Lancet. Infectious diseases.

[354]  K. Poehling,et al.  Influenza Burden for Children With Asthma , 2008, Pediatrics.

[355]  P. Mangtani,et al.  Influenza vaccination in pregnancy: current evidence and selected national policies. , 2008, The Lancet. Infectious diseases.

[356]  D. Bernstein,et al.  Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age , 2008, Pediatrics.

[357]  J. Cavanaugh,et al.  Relationship of Influenza Vaccination Declination Statements and Influenza Vaccination Rates for Healthcare Workers in 22 US Hospitals , 2008, Infection Control &#x0026; Hospital Epidemiology.

[358]  Influenza activity--United States and worldwide, 2007-08 season. , 2008, MMWR. Morbidity and mortality weekly report.

[359]  M. Braun,et al.  Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine. , 2008, Vaccine.

[360]  T. Beebe,et al.  Influenza Vaccination Among Registered Nurses: Information Receipt, Knowledge, and Decision-Making at an Institution With a Multifaceted Educational Program , 2008, Infection Control &#x0026; Hospital Epidemiology.

[361]  A. Osterhaus,et al.  Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[362]  A. Monto,et al.  Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. , 2008, The Journal of infectious diseases.

[363]  J. Cavanaugh,et al.  Elements of influenza vaccination programs that predict higher vaccination rates: results of an emerging infections network survey. , 2008, Clinical Infectious Diseases.

[364]  Cathleen K. Yoshida,et al.  Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders. , 2008, American journal of obstetrics and gynecology.

[365]  A. Lackenby,et al.  The potential impact of neuraminidase inhibitor resistant influenza , 2008, Current opinion in infectious diseases.

[366]  C. Kȩpka,et al.  Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. , 2008, European heart journal.

[367]  J. P. Davis,et al.  Human Case of Swine Influenza A (H1N1) Triple Reassortant Virus Infection, Wisconsin , 2008, Emerging infectious diseases.

[368]  Zhongjie Li,et al.  Clinical Characteristics of 26 Human Cases of Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in China , 2008, PLoS ONE.

[369]  A. Fernández-Sesma,et al.  A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[370]  Colin A. Russell,et al.  The Global Circulation of Seasonal Influenza A (H3N2) Viruses , 2008, Science.

[371]  C. Dekker,et al.  An Algorithm for Treatment of Patients With Hypersensitivity Reactions After Vaccines , 2008, Pediatrics.

[372]  Ross Upshur,et al.  The Effect of Universal Influenza Immunization on Mortality and Health Care Use , 2008, PLoS medicine.

[373]  F. Hayden,et al.  Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. , 2008, Vaccine.

[374]  Cécile Viboud,et al.  Multiple Reassortment Events in the Evolutionary History of H1N1 Influenza A Virus Since 1918 , 2008, PLoS pathogens.

[375]  L. Magder,et al.  Countywide School-Based Influenza Immunization: Direct and Indirect Impact on Student Absenteeism , 2008, Pediatrics.

[376]  Yu Wang,et al.  Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China , 2008, The Lancet.

[377]  J. Stockman Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old , 2008 .

[378]  R. Belshe,et al.  Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. , 2008, Vaccine.

[379]  Ron A M Fouchier,et al.  Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans , 2009, Science.

[380]  I. Barr,et al.  Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[381]  T. Uyeki,et al.  Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[382]  P. Barboza,et al.  The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the Pacific. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[383]  Lyn Finelli,et al.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. , 2009, The New England journal of medicine.

[384]  K. Edwards,et al.  Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. , 2009, Vaccine.

[385]  R. Heine,et al.  Egg allergy in childhood: an update , 2009, Current opinion in allergy and clinical immunology.

[386]  Md. Mahmudur Rahman,et al.  Avian Influenza Virus A (H5N1), Detected through Routine Surveillance, in Child, Bangladesh , 2009, Emerging infectious diseases.

[387]  F. Carrat,et al.  Effect of Influenza Vaccination of Nursing Home Staff on Mortality of Residents: A Cluster‐Randomized Trial , 2009, Journal of the American Geriatrics Society.

[388]  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. , 2009, Emerging infectious diseases.

[389]  D. Fleming,et al.  Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[390]  M. Biggerstaff,et al.  H1N1 2009 influenza virus infection during pregnancy in the USA , 2009, The Lancet.

[391]  Mandy A. Allison,et al.  High influenza vaccination coverage in children with high-risk conditions during a vaccine shortage. , 2009, Archives of pediatrics & adolescent medicine.

[392]  A. Falsey,et al.  Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. , 2009, The Journal of infectious diseases.

[393]  Jean A. Roayaei,et al.  Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. , 2009, JAMA.

[394]  A. Schuchat Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[395]  L. Finelli,et al.  Emergence of a novel swine-origin influenza A (H1N1) virus in humans. , 2009, The New England journal of medicine.

[396]  M. McDonald,et al.  Protection of racial/ethnic minority populations during an influenza pandemic. , 2009, American journal of public health.

[397]  A. Shane Effectiveness of Maternal Influenza Immunization in Mothers and Infants , 2009 .

[398]  Ross Upshur,et al.  The effect of universal influenza immunization on antibiotic prescriptions: an ecological study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[399]  A. Monto,et al.  Comparative efficacy of inactivated and live attenuated influenza vaccines. , 2009, The New England journal of medicine.

[400]  Lynnette Brammer,et al.  Estimates of US influenza‐associated deaths made using four different methods , 2009, Influenza and other respiratory viruses.

[401]  S. Lapinsky,et al.  Critically Ill patients with 2009 influenza A(H1N1) in Mexico. , 2009, JAMA.

[402]  A. Monto,et al.  Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. , 2009, Vaccine.

[403]  Tanja Popovic,et al.  Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[404]  M. Halloran,et al.  Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States , 2009, American journal of epidemiology.

[405]  A. Fiore,et al.  Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.

[406]  N. Khardori,et al.  Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 , 2009 .

[407]  A. Mack,et al.  Continuing Increases in Autism Reported to California’s Developmental Services System: Mercury in Retrograde , 2009 .

[408]  L. Balluz,et al.  Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[409]  D. Vugia,et al.  Hospitalized patients with novel influenza A (H1N1) virus infection - California, April-May, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[410]  Libo Dong,et al.  Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.

[411]  A. Fiore,et al.  Influenza vaccination coverage among children aged 6-23 months - United States, 2007-08 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.

[412]  N. Andrews,et al.  Original Contribution Investigation of the Temporal Association of Guillain-Barré Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database , 2009 .

[413]  M. Meade,et al.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada. , 2009, JAMA.

[414]  Gerry Barber,et al.  Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[415]  C. del Rio,et al.  Safety of influenza vaccination during pregnancy. , 2009, American journal of obstetrics and gynecology.

[416]  C. Bridges,et al.  Death and serious illness following influenza vaccination: a multidisciplinary investigation , 2009, Pharmacoepidemiology and drug safety.

[417]  Stefan Gravenstein,et al.  Influenza estacional en adultos y niños—Diagnóstico, tratamiento, quimioprofilaxis y control de brotes institucionales: Guías de práctica clínica de la Sociedad de Enfermedades Infecciosas de Estados Unidos de América , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[418]  A. Stewart Mandatory vaccination of health care workers. , 2009, The New England journal of medicine.

[419]  C. Bridges,et al.  Estimating influenza-associated deaths in the United States. , 2009, American journal of public health.

[420]  R. Porcher,et al.  Guillain-Barré syndrome and influenza virus infection. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[421]  C. Weinbaum,et al.  Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[422]  Simon Cauchemez,et al.  CME ACTIVITY: Face Mask Use and Control of Respiratory Virus Transmission in Households , 2009, Emerging infectious diseases.

[423]  Bruce A. Ong,et al.  Does Influenza Vaccination Improve Pediatric Asthma Outcomes? , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[424]  C. Fraser,et al.  Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. , 2009, The New England journal of medicine.

[425]  C. Reed,et al.  Infection With Community-Onset Staphylococcus aureus and Influenza Virus in Hospitalized Children , 2009, The Pediatric infectious disease journal.

[426]  Robert Schechter,et al.  Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.

[427]  S. Salmaso,et al.  Neuropsychological Performance 10 Years After Immunization in Infancy With Thimerosal-Containing Vaccines , 2009, Pediatrics.

[428]  Wang Guansong,et al.  Update on avian influenza A (H5N1) virus infection in humans , 2009 .

[429]  C. Reed,et al.  Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[430]  L. Balluz,et al.  Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season. , 2009, MMWR. Morbidity and mortality weekly report.

[431]  R. Bryan,et al.  Pandemic influenza preparedness and vulnerable populations in tribal communities. , 2009, American journal of public health.

[432]  G. Euler,et al.  Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey. , 2009, American journal of preventive medicine.

[433]  Abstr Act,et al.  Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand , 2009 .

[434]  S. Humiston,et al.  Cost of Universal Influenza Vaccination of Children in Pediatric Practices , 2009, Pediatrics.

[435]  C. Wichems,et al.  Response to a monovalent 2009 influenza A (H1N1) vaccine. , 2009, The New England journal of medicine.

[436]  D. Burwen,et al.  Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. , 2009, Vaccine.

[437]  S. Arifeen,et al.  Influenza immunization in pregnancy--antibody responses in mothers and infants. , 2010, The New England journal of medicine.

[438]  E. Tuomanen,et al.  Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. , 2010, The New England journal of medicine.

[439]  N. Andrews,et al.  Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study , 2010, The Lancet.

[440]  C. Bauch,et al.  Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis , 2010, PLoS medicine.

[441]  Chih-Jen Wei,et al.  Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design , 2010, Science Translational Medicine.

[442]  M. Eichelberger,et al.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host. , 2010, The Journal of infectious diseases.

[443]  V. Fraser,et al.  Influenza Vaccination among Healthcare Workers: Ten-Year Experience of a Large Healthcare Organization , 2010, Infection Control &#x0026; Hospital Epidemiology.

[444]  S. Bezerra,et al.  Lung pathology in fatal novel human influenza A (H1N1) infection. , 2010, American journal of respiratory and critical care medicine.

[445]  Atlanta,et al.  Interim results: state-specific seasonal influenza vaccination coverage - United States, August 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[446]  Licensure of a high-dose inactivated influenza vaccine for persons aged >or=65 years (Fluzone High-Dose) and guidance for use - United States, 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[447]  Karen Ekernas,et al.  Facemasks and Hand Hygiene to Prevent Influenza Transmission in Households: A Cluster Randomized Trial , 2010 .

[448]  F. Polack,et al.  Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. , 2010, The New England journal of medicine.

[449]  A. Kallen,et al.  Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents - three states, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[450]  Benjamin J Cowling,et al.  Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research. , 2010, American journal of infection control.

[451]  Steve Doucette,et al.  Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection , 2010, Canadian Medical Association Journal.

[452]  Craig M. Hales,et al.  Influenza immunization coverage among residents of long-term care facilities certified by CMS, 2005-2006: the newest MDs quality indicator. , 2010, Journal of the American Medical Directors Association.

[453]  Y Zhou,et al.  Face masks to prevent transmission of influenza virus: a systematic review , 2010, Epidemiology and Infection.

[454]  L. Balluz,et al.  Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage --- United States, October-December 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[455]  J. Stockman Influenza-Associated Pediatric Mortality in the United States: Increase of Staphylococcus aureus Coinfection , 2010 .

[456]  W. Callaghan,et al.  Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. , 2010, JAMA.

[457]  L. Brammer,et al.  Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[458]  M. Blatter,et al.  Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials , 2010, The Lancet.

[459]  P. Horby,et al.  A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. , 2010, The New England journal of medicine.

[460]  Allison E Aiello,et al.  Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. , 2010, The Journal of infectious diseases.

[461]  T. Santibanez,et al.  Behavior and beliefs about influenza vaccine among adults aged 50-64 years. , 2010, American journal of health behavior.

[462]  Ruihua Yin,et al.  Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. , 2010, American journal of epidemiology.

[463]  P. Effler,et al.  Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA , 2010, Emerging infectious diseases.

[464]  S. Schrag,et al.  Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. , 2010, The Journal of infectious diseases.

[465]  Update on human cases of highly pathogenic avian influenza A (H5N1) infection: 2009. , 2010, Releve epidemiologique hebdomadaire.

[466]  W. Parmet Pandemic vaccines--the legal landscape. , 2010, The New England journal of medicine.

[467]  J. Tokars,et al.  H1N1 vaccine safety monitoring: beyond background rates , 2010, The Lancet.

[468]  L. Finelli,et al.  Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women , 2010, Obstetrics and gynecology.

[469]  A. Fowlkes,et al.  Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease , 2010, PloS one.

[470]  M. Honein,et al.  Severe 2009 H1N1 influenza in pregnant and postpartum women in California. , 2010, The New England journal of medicine.

[471]  Atlanta,et al.  2009 pandemic influenza A (H1N1) in pregnant women requiring intensive care - New York City, 2009. , 2010, MMWR. Morbidity and mortality weekly report.

[472]  J. Sejvar,et al.  Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. , 2010, MMWR. Morbidity and mortality weekly report.

[473]  A. Arguedas,et al.  Responses to 2009 H1N1 vaccine in children 3 to 17 years of age. , 2010, The New England journal of medicine.

[474]  W. C. Dunagan,et al.  Mandatory influenza vaccination of health care workers: translating policy to practice. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[475]  Tom Jefferson,et al.  Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.

[476]  D. Earn,et al.  Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. , 2010, JAMA.

[477]  J. McVernon,et al.  Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. , 2010, JAMA.

[478]  P. Valdez,et al.  Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. , 2010, American journal of respiratory and critical care medicine.

[479]  L. Balluz,et al.  Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. , 2010, MMWR. Morbidity and mortality weekly report.

[480]  A. Pavia Mandate to protect patients from health care-associated influenza. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[481]  Update: influenza activity - United States, August 30, 2009-March 27, 2010, and composition of the 2010-11 influenza vaccine. , 2010, MMWR. Morbidity and mortality weekly report.

[482]  W. Choi,et al.  Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence. , 2010, Vaccine.

[483]  H. A. Cook,et al.  Fatalities associated with the 2009 H1N1 influenza A virus in New York city. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[484]  S. Black,et al.  Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines , 2009, The Lancet.

[485]  Víctor Hugo Borja-Aburto,et al.  Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis , 2009, The Lancet.

[486]  Mark A. Miller,et al.  Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons , 2010, PLoS currents.

[487]  Jeannine S. Schiller,et al.  Early release of selected estimates based on data from the January-March 2011 National Health Interview Survey , 2011 .

[488]  J. McCullers,et al.  Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. , 2011, Vaccine.

[489]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.

[490]  Recommended Adult Immunization Schedule: United States, 2012* , 2012, Annals of Internal Medicine.

[491]  S. Esposito,et al.  Live attenuated intranasal influenza vaccine , 2012, Human vaccines & immunotherapeutics.

[492]  T. Lieu,et al.  Non-Traditional Settings for Influenza Vaccination of Adults , 2012, PharmacoEconomics.